Velocity of Content

JANUARY 26, 2022

In RightFind, reseachers and investigators can analyze previously published studies and create reviews of articles pertaining to a topic, such as a specific disease, chemical compound, or ingredient. In this sense, facilitating collaboration can mean organizing access to the latest approved literature to quickly answer client inquiries.

Marketing 95

Marketing Marketing Licensing Publishing 95

SpicyIP

MARCH 4, 2024

Here is another round of SpicyIP flashbacks by Lokesh, where he looks into a variety of topics ranging from IP and Gaming to Biodiversity and Benefit Sharing! approval for their under trial AI models. Do let us know your thoughts on these mini-guides in the comments below! Blue Dart secures well known trademark status.

Invention 59

Invention Trademark IP Patent 59

LexBlog IP

OCTOBER 19, 2023

On this topic, FDA asks: What nonclinical studies could be leveraged in support of a related product using similar technologies? On this topic, FDA asks: What are challenges and strategies/opportunities with interpreting efficacy data from individual patients (including expanded access) and small groups of patients?

Editing 52

Editing Designs Design Technology 52

43(B)log

AUGUST 9, 2021

5, 2021) Scilex sells an FDA-approved, prescription-strength topical analgesic self-adhesive patch, ZTlido (lidocaine), which is allegedly often prescribed off-label, including for general neuropathic pain (e.g., FDA-approved.’ ” That was more than merely putting a product on the market. More is required to imply FDA approval.”

False Advertising 59

False Advertising Advertising Advertising Marketing 59

Patently-O

SEPTEMBER 26, 2022

Topics: Enablement / Written Description (All three are biotech / pharma): 3 Cases; Infringement (FDA Labeling): 1 Case; Anticipation (On Sale Bar): 1 Case; Double Patenting (Still the law?) Biogen’s patent claims is directed toward a drug treatment for multiple sclerosis.

Patent Law 126

Patent Law Law Patent Invention 126

Fish & Richardson Trademark & Copyright Thoughts

JANUARY 11, 2022

2021 saw several important milestones in the biosimilars space, including the much anticipated first interchangeable designations by FDA and the approval of the first ophthalmology biosimilar. Yet, given fewer FDA approvals in 2020 and 2021, this year saw the lowest number of commercial launches since 2017. Introduction. Conclusion.

Litigation 52

Litigation Settlement Patent Marketing 52

Fish & Richardson Trademark & Copyright Thoughts

DECEMBER 2, 2020

As with any growing industry, cannabis stakeholders are eager to protect their valuable intellectual property (IP) rights, but their ability to obtain comprehensive IP protection and enforce their IP rights is sometimes in conflict with federal drug law. THC from Schedule I.

IP 52

IP Registration Trademark Branding 52

Patently-O

NOVEMBER 29, 2023

Article III standing remains a hot topic at all levels of federal litigation and across many different areas of law. With surgery as the only viable course of treatment, Cloudbreak Therapeutics created a topical application of multikinase inhibitors to provide a non-surgical treatment to prevent recurring tumors, which is recognized in U.S.

Art 49

Art Business Patent Settlement 49

The IPKat

SEPTEMBER 4, 2023

Case Background: XADAGO Newron v Comptroller related to Newron pharmaceutical UK SPC application for its branded Parkinson's disease drug XADAGO ( SPC/GB15/046 ). It is common practice for new therapeutics to be approved for use in patients who are also receiving standard-of-care.

Art 117

Art Marketing Marketing Patent 117

SpicyIP

JULY 26, 2021

Topical Highlight. In this post , Praharsh discussed the recent Delhi High Court order vacating an ex-parte interim injunction, allowing the SMS Pharmaceuticals to export Merck’s patented anti-diabetic drug ‘Sitagliptin’ for R&D purposes. July 20, 2021]. The Delhi High Court in Sony Pictures Networks India Pvt Ltd v.

Copyright 97

Copyright Patent Television Intellectual Property 97

LexBlog IP

DECEMBER 31, 2022

In the intellectual property (IP) space, there has been explosive growth in this area, with AI-based patent filings addressing trending areas, including disease identification and diagnosis, drug discovery, personalized medicine, and clinical trials, among others. Drug Discovery and Manufacture. Radiotherapy and Radiology.

Intellectual Property 52

Intellectual Property IP Technology Privacy 52

The IPKat

DECEMBER 5, 2021

The message was met with the approval of the majority of the music community , which noted that each artist recognizes clear choices of creativity not only in the creative process of the individual song but also in the choice of the exact order in which they should appear on an album.

Moral Rights 143

Moral Rights Music Television Copyright 143

SpicyIP

JULY 9, 2021

This approach has been approved in several jurisdictions. Under the Trade-Related Aspects of Intellectual Property Rights Treaty (TRIPS), India and South Africa presented a proposal to the World Trade Organization (WTO) to waive drug companies’ intellectual property rights for Covid-19 vaccines and treatments. In Altavion, Inc.

Patent 119

Patent Invention Intellectual Property Public Domain 119

LexBlog IP

SEPTEMBER 9, 2022

Director Vidal highlights four different topics as they relate to the duty of disclosure standard: 1. .” This notice comes after the recent Executive Order on Promoting Competition in the American Economy and a letter from Senator Patrick Leahy and Thom Tillis to the USPTO to reduce conflicting statements among government agencies.

Government 52

Government Intellectual Property Marketing Marketing 52

43(B)log

MARCH 25, 2024

Food & Drug Admin., NIFLA says that abortion is a controversial topic, making disclosures about abortion controversial; but NetChoice said that “ disclosures of social media censorship decisions” were not controversial. R J Reynolds Tobacco Co. 2024 WL 1208111, F.4th 23-40076 (5 th Cir.

Advertising 64

Advertising Advertising Social Media Government 64

SpicyIP

DECEMBER 24, 2023

In this month’s edition, he looks into topics including the Plant Variety Registry, different tales of/ takes on personality rights, and multiple leaks of key documents and their contribution in law-making. vs The Controller of Patents & Anr. 6 of the Biological Diversity Act. Pharmacyclics LLC & Anr.

Registration 52

Registration Trademark Copyright Registering Trademarks 52

SpicyIP

JULY 19, 2021

Topical Highlight. The National Pharmaceutical Pricing Authority (NPPA) has invoked the terms of paragraph 19 of the Drugs Prices Control Order (DPCO) – 2013 to cap the price of five medical devices: a pulse oximeter, a blood pressure monitoring machine, a nebulizer, a digital thermometer, and a glucometer. News from India.

Advertising 105

Advertising Advertising Non-Fungible Tokens Intellectual Property 105